Related Experiment Video
Updated: Jul 27, 2025
05:54
MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
Published on: December 13, 2017
14.1K
Intravenous Magnesium Sulfate Reduces Tremor Severity: A Case Series
Alternative Therapies in Health and Medicine
|June 9, 2023
Summary
Intravenous magnesium sulfate shows promise for managing tremors, offering temporary relief and improved daily function in patients. Further research is recommended to quantify its effects.
Area of Science:
- Neurology
- Integrative Medicine
Background:
- Tremors, often associated with Parkinson's disease (PD), are typically managed with dopamine agonists, which have limited long-term efficacy.
- The prevalence of PD is projected to double, necessitating low-cost complementary and integrative health interventions.
- Magnesium sulfate is explored for its potential therapeutic benefits in managing tremors.
Purpose of the Study:
- To investigate the efficacy of intravenous (IV) magnesium sulfate in managing tremors.
- To present findings from a case series of four patients receiving IV magnesium sulfate treatment.
Main Methods:
- Four patients with tremors received IV magnesium sulfate treatment at the National University of Natural Medicine clinic.
- Treatment involved an initial dose of 2000 mg, with increments up to 3500 mg, following safety screenings (ATHUMB acronym).
Main Results:
- All patients experienced reduced tremor severity during and after IV magnesium sulfate treatment.
- Patients reported a 24-48 hour window of relief and improved daily living activities.
- Three out of four patients noted extended relief for 5-7 days.
Conclusions:
- Intravenous magnesium sulfate demonstrated effectiveness in reducing tremor severity.
- Future research should utilize objective and self-reported measures to quantify the impact and duration of IV magnesium sulfate's effects on tremors.
More Related Videos
Related Concept Videos
01:28Classification of Skeletal Muscle Relaxants
2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K
01:21Skeletal Muscle Relaxants: Adverse Effects
404
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
404
01:24Mania and Antimanic Drugs: Overview
258
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
258
01:31Skeletal Muscle Relaxants: Therapeutic Uses
523
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
523
01:29Spasmolytic Agents: Chemical Classification
951
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
951
01:24Parkinson's Disease: Treatment
305
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
305